Global Companion Diagnostic Tests in Oncology Market 2018 - Industry Research Report

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE
 

Global Companion Diagnostic Tests in Oncology Market 2018 - Industry Research Report

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 94   |    Publisher : Extense Research

This report focuses on the global Companion Diagnostic Tests in Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostic Tests in Oncology development in United States, Europe and China.

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.
In 2017, the global Companion Diagnostic Tests in Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
    Abbott
    Roche
    Genomic Health
    QIAGEN
    Agilent
    Agendia
    BioMerieux
    Illumina
    Siemens Healthcare
    Thermo Fisher

Market segment by Type, the product can be split into
    Protein Detection
    DNA Detection

Market segment by Application, split into
    Pharmaceutical & Biotechnology Companies
    Medical Device Companies
    Research Institutes

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Companion Diagnostic Tests in Oncology status, future forecast, growth opportunity, key market and key players.
    To present the Companion Diagnostic Tests in Oncology development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Companion Diagnostic Tests in Oncology are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (2013-2025)
        1.4.2 Protein Detection
        1.4.3 DNA Detection
    1.5 Market by Application
        1.5.1 Global Companion Diagnostic Tests in Oncology Market Share by Application (2013-2025)
        1.5.2 Pharmaceutical & Biotechnology Companies
        1.5.3 Medical Device Companies
        1.5.4 Research Institutes
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Companion Diagnostic Tests in Oncology Market Size
    2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions
        2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions (2013-2025)
        2.2.2 Companion Diagnostic Tests in Oncology Market Share by Regions (2013-2018)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Companion Diagnostic Tests in Oncology Market Size by Manufacturers
        3.1.1 Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2013-2018)
        3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Manufacturers (2013-2018)
        3.1.3 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
    3.2 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
    3.3 Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service
    3.4 Date of Enter into Companion Diagnostic Tests in Oncology Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018)
    4.2 Global Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018)

5 United States
    5.1 United States Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    5.2 Companion Diagnostic Tests in Oncology Key Players in United States
    5.3 United States Companion Diagnostic Tests in Oncology Market Size by Type
    5.4 United States Companion Diagnostic Tests in Oncology Market Size by Application

6 Europe
    6.1 Europe Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    6.2 Companion Diagnostic Tests in Oncology Key Players in Europe
    6.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type
    6.4 Europe Companion Diagnostic Tests in Oncology Market Size by Application

7 China
    7.1 China Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    7.2 Companion Diagnostic Tests in Oncology Key Players in China
    7.3 China Companion Diagnostic Tests in Oncology Market Size by Type
    7.4 China Companion Diagnostic Tests in Oncology Market Size by Application

8 Japan
    8.1 Japan Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    8.2 Companion Diagnostic Tests in Oncology Key Players in Japan
    8.3 Japan Companion Diagnostic Tests in Oncology Market Size by Type
    8.4 Japan Companion Diagnostic Tests in Oncology Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    9.2 Companion Diagnostic Tests in Oncology Key Players in Southeast Asia
    9.3 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type
    9.4 Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application

10 India
    10.1 India Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    10.2 Companion Diagnostic Tests in Oncology Key Players in India
    10.3 India Companion Diagnostic Tests in Oncology Market Size by Type
    10.4 India Companion Diagnostic Tests in Oncology Market Size by Application

11 Central & South America
    11.1 Central & South America Companion Diagnostic Tests in Oncology Market Size (2013-2018)
    11.2 Companion Diagnostic Tests in Oncology Key Players in Central & South America
    11.3 Central & South America Companion Diagnostic Tests in Oncology Market Size by Type
    11.4 Central & South America Companion Diagnostic Tests in Oncology Market Size by Application

12 International Players Profiles
    12.1 Abbott
        12.1.1 Abbott Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Companion Diagnostic Tests in Oncology Introduction
        12.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.1.5 Abbott Recent Development
    12.2 Roche
        12.2.1 Roche Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Companion Diagnostic Tests in Oncology Introduction
        12.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.2.5 Roche Recent Development
    12.3 Genomic Health
        12.3.1 Genomic Health Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Companion Diagnostic Tests in Oncology Introduction
        12.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.3.5 Genomic Health Recent Development
    12.4 QIAGEN
        12.4.1 QIAGEN Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Companion Diagnostic Tests in Oncology Introduction
        12.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.4.5 QIAGEN Recent Development
    12.5 Agilent
        12.5.1 Agilent Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Companion Diagnostic Tests in Oncology Introduction
        12.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.5.5 Agilent Recent Development
    12.6 Agendia
        12.6.1 Agendia Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Companion Diagnostic Tests in Oncology Introduction
        12.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.6.5 Agendia Recent Development
    12.7 BioMerieux
        12.7.1 BioMerieux Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Companion Diagnostic Tests in Oncology Introduction
        12.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.7.5 BioMerieux Recent Development
    12.8 Illumina
        12.8.1 Illumina Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Companion Diagnostic Tests in Oncology Introduction
        12.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.8.5 Illumina Recent Development
    12.9 Siemens Healthcare
        12.9.1 Siemens Healthcare Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Companion Diagnostic Tests in Oncology Introduction
        12.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.9.5 Siemens Healthcare Recent Development
    12.10 Thermo Fisher
        12.10.1 Thermo Fisher Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Companion Diagnostic Tests in Oncology Introduction
        12.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)
        12.10.5 Thermo Fisher Recent Development

13 Market Forecast 2018-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2018-2025)
    13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details



List of Tables and Figures

    Table Companion Diagnostic Tests in Oncology Key Market Segments
    Table Key Players Companion Diagnostic Tests in Oncology Covered
    Table Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type 2013-2025 (Million US$)
    Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type 2013-2025
    Figure Protein Detection Figures
    Table Key Players of Protein Detection
    Figure DNA Detection Figures
    Table Key Players of DNA Detection
    Table Global Companion Diagnostic Tests in Oncology Market Size Growth by Application 2013-2025 (Million US$)
    Figure Pharmaceutical & Biotechnology Companies Case Studies
    Figure Medical Device Companies Case Studies
    Figure Research Institutes Case Studies
    Figure Companion Diagnostic Tests in Oncology Report Years Considered
    Table Global Companion Diagnostic Tests in Oncology Market Size 2013-2025 (Million US$)
    Figure Global Companion Diagnostic Tests in Oncology Market Size and Growth Rate 2013-2025 (Million US$)
    Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2013-2025 (Million US$)
    Table Global Companion Diagnostic Tests in Oncology Market Size by Regions 2013-2018 (Million US$)
    Table Global Companion Diagnostic Tests in Oncology Market Share by Regions 2013-2018
    Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions 2013-2018
    Figure Global Companion Diagnostic Tests in Oncology Market Share by Regions 2018
    Table Market Top Trends
    Table Global Companion Diagnostic Tests in Oncology Revenue by Manufacturers (2013-2018) (Million US$)
    Table Global Companion Diagnostic Tests in Oncology Market Share by Manufacturers (2013-2018)
    Figure Global Companion Diagnostic Tests in Oncology Market Share by Manufacturers in 2018
    Table Global Companion Diagnostic Tests in Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Companion Diagnostic Tests in Oncology Product/Solution/Service
    Table Date of Enter into Companion Diagnostic Tests in Oncology Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table Global Companion Diagnostic Tests in Oncology Market Size Share by Type (2013-2018)
    Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Type (2013-2018)
    Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2013-2018)
    Figure Global Companion Diagnostic Tests in Oncology Market Size Market Share by Application (2013-2018)
    Figure Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application in 2017
    Figure United States Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table United States Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table United States Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table United States Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table United States Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table United States Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table United States Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Figure Europe Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table Europe Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table Europe Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table Europe Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table Europe Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table Europe Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table Europe Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Figure China Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table China Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table China Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table China Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table China Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table China Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table China Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Figure Japan Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table Japan Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table Japan Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table Japan Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table Japan Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table Japan Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table Japan Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table Southeast Asia Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table Southeast Asia Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table Southeast Asia Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table Southeast Asia Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Figure India Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table India Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table India Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table India Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table India Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table India Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table India Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Figure Central & South America Companion Diagnostic Tests in Oncology Market Size 2013-2018 (Million US$)
    Table Central & South America Key Players Companion Diagnostic Tests in Oncology Revenue (2017-2018) (Million US$)
    Table Central & South America Key Players Companion Diagnostic Tests in Oncology Market Share (2017-2018)
    Table Central & South America Companion Diagnostic Tests in Oncology Market Size by Type (2013-2018) (Million US$)
    Table Central & South America Companion Diagnostic Tests in Oncology Market Share by Type (2013-2018)
    Table Central & South America Companion Diagnostic Tests in Oncology Market Size by Application (2013-2018) (Million US$)
    Table Central & South America Companion Diagnostic Tests in Oncology Market Share by Application (2013-2018)
    Table Abbott Company Details
    Table Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018) (Million US$)
    Figure Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Abbott Recent Development
    Table Roche Company Details
    Table Roche Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Roche Recent Development
    Table Genomic Health Company Details
    Table Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Genomic Health Recent Development
    Table QIAGEN Company Details
    Table QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table QIAGEN Recent Development
    Table Agilent Company Details
    Table Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Agilent Recent Development
    Table Agendia Company Details
    Table Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Agendia Recent Development
    Table BioMerieux Company Details
    Table BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table BioMerieux Recent Development
    Table Illumina Company Details
    Table Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Illumina Recent Development
    Table Siemens Healthcare Company Details
    Table Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Siemens Healthcare Recent Development
    Table Thermo Fisher Company Details
    Table Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2013-2018)(Million US$)
    Figure Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2013-2018)
    Table Thermo Fisher Recent Development
    Table Global Companion Diagnostic Tests in Oncology Market Size by Regions (Million US$) 2018-2025
    Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions (2018-2025)
    Figure Global Companion Diagnostic Tests in Oncology Market Size Share by Regions in 2025
    Figure United States Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Figure Europe Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Figure China Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Figure Japan Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Figure Southeast Asia Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Figure India Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Figure Central & South America Companion Diagnostic Tests in Oncology Market Size Forecast (2018-2025)(Million USD)
    Table Global Companion Diagnostic Tests in Oncology Market Size by Product (2018-2025) (Million US$)
    Figure Global Companion Diagnostic Tests in Oncology Market Size by Product (2018-2025)
    Figure Global Companion Diagnostic Tests in Oncology Market Size by Product in 2025
    Table Global Companion Diagnostic Tests in Oncology Market Size by Application (2018-2025) (Million US$)
    Figure Global Companion Diagnostic Tests in Oncology Market Size by Application (2018-2025)
    Figure Global Companion Diagnostic Tests in Oncology Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@extentresearch.com